These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10727548)

  • 1. Treatment with different doses of folic acid in haemodialysis patients: effects on folate distribution and aminothiol concentrations.
    Arnadottir M; Gudnason V; Hultberg B
    Nephrol Dial Transplant; 2000 Apr; 15(4):524-8. PubMed ID: 10727548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12.
    Billion S; Tribout B; Cadet E; Queinnec C; Rochette J; Wheatley P; Bataille P
    Nephrol Dial Transplant; 2002 Mar; 17(3):455-61. PubMed ID: 11865092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of folinic versus folic acid for the correction of hyperhomocysteinemia in hemodialysis patients.
    Hauser AC; Hagen W; Rehak PH; Buchmayer H; Födinger M; Papagiannopoulos M; Bieglmayer C; Apsner R; Köller E; Ignatescu M; Hörl WH; Sunder-Plassmann G
    Am J Kidney Dis; 2001 Apr; 37(4):758-65. PubMed ID: 11273876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients.
    van Guldener C; Janssen MJ; de Meer K; Donker AJ; Stehouwer CD
    J Intern Med; 1999 Feb; 245(2):175-83. PubMed ID: 10081520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
    Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
    Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12.
    Ducloux D; Aboubakr A; Motte G; Toubin G; Fournier V; Chalopin JM; Drüeke T; Massy ZA
    Nephrol Dial Transplant; 2002 May; 17(5):865-70. PubMed ID: 11981075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylenetetrahydrofolate reductase 677C-->T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: a randomized controlled trial.
    Ashfield-Watt PA; Pullin CH; Whiting JM; Clark ZE; Moat SJ; Newcombe RG; Burr ML; Lewis MJ; Powers HJ; McDowell IF
    Am J Clin Nutr; 2002 Jul; 76(1):180-6. PubMed ID: 12081832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.
    van Ede AE; Laan RF; Blom HJ; Boers GH; Haagsma CJ; Thomas CM; De Boo TM; van de Putte LB
    Rheumatology (Oxford); 2002 Jun; 41(6):658-65. PubMed ID: 12048292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages.
    Nelen WL; Blom HJ; Thomas CM; Steegers EA; Boers GH; Eskes TK
    J Nutr; 1998 Aug; 128(8):1336-41. PubMed ID: 9687553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A C677T mutation in the methylenetetrahydrofolate reductase gene modifies serum cysteine in dialysis patients.
    Kimura H; Gejyo F; Suzuki S; Takeda T; Miyazaki R; Yoshida H
    Am J Kidney Dis; 2000 Nov; 36(5):925-33. PubMed ID: 11054348
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Huang X; Qin X; Yang W; Liu L; Jiang C; Zhang X; Jiang S; Bao H; Su H; Li P; He M; Song Y; Zhao M; Yin D; Wang Y; Zhang Y; Li J; Yang R; Wu Y; Hong K; Wu Q; Chen Y; Sun N; Li X; Tang G; Wang B; Cai Y; Hou FF; Huo Y; Wang H; Wang X; Cheng X
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):679-685. PubMed ID: 29371246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
    Azadibakhsh N; Hosseini RS; Atabak S; Nateghiyan N; Golestan B; Rad AH
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):779-88. PubMed ID: 19736473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of L-folinic or folic acid.
    Ghandour H; Bagley PJ; Shemin D; Hsu N; Jacques PF; Dworkin L; Bostom AG; Selhub J
    Kidney Int; 2002 Dec; 62(6):2246-9. PubMed ID: 12427152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C677T MTHFR genotypes influence the efficacy of B9 and B12 vitamins supplementation to lowering plasma total homocysteine in hemodialysis.
    Achour O; Elmtaoua S; Zellama D; Omezzine A; Moussa A; Rejeb J; Boumaiza I; Bouacida L; Rejeb NB; Achour A; Bouslama A
    J Nephrol; 2016 Oct; 29(5):691-8. PubMed ID: 26559681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
    D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
    Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease.
    Hyndman ME; Manns BJ; Snyder FF; Bridge PJ; Scott-Douglas NW; Fung E; Parsons HG
    Metabolism; 2003 Feb; 52(2):168-72. PubMed ID: 12601627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipients.
    Beaulieu AJ; Gohh RY; Han H; Hakas D; Jacques PF; Selhub J; Bostom AG
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2918-21. PubMed ID: 10591669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
    Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
    J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine, vitamin B12, serum and erythrocyte folate in peritoneal dialysis patients.
    De Vecchi AF; Bamonti-Catena F; Finazzi S; Patrosso C; Taioli E; Novembrino C; Colucci P; Lando G; De Franceschi M; Marocchi A; Maiolo AT
    Clin Nephrol; 2001 Apr; 55(4):313-7. PubMed ID: 11334318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperhomocysteinemia and oxidative stress in hemodialysis: effects of supplementation with folic acid.
    Chiarello PG; Vannucchi MT; Moysés Neto M; Vannucchi H
    Int J Vitam Nutr Res; 2003 Nov; 73(6):431-8. PubMed ID: 14743547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.